Research programme: antibacterials - Roche
Alternative Names: 3,5-Diamino-piperidinyl triazines (DAPT) compounds - Roche; Bacteria ribosomal translation inhibitors - Roche; Bacterial translation inhibitors - Roche; DAPT antibacterials - RocheLatest Information Update: 21 Feb 2017
At a glance
- Originator Anadys Pharmaceuticals
- Class Small molecules; Triazines
- Mechanism of Action Cell wall inhibitors; Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Nosocomial infections
Most Recent Events
- 04 Apr 2006 This programme is still in active development
- 25 Jun 2004 This programme is still in active development - BIO 2004 Annual International Convention (BIO-2004)
- 13 Jun 2002 Preclinical trials in Nosocomial infections in USA (unspecified route)